NYSE:MCK - McKesson Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$115.20 +2.73 (+2.43 %)
(As of 04/23/2019 04:00 PM ET)
Previous Close$112.47
Today's Range$112.2260 - $116.38
52-Week Range$106.11 - $160.84
Volume936,825 shs
Average Volume1.53 million shs
Market Capitalization$22.10 billion
P/E Ratio9.13
Dividend Yield1.39%
Beta1.24
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP58155Q10
Phone415-983-8300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$208.36 billion
Cash Flow$28.4444 per share
Book Value$48.74 per share

Profitability

Net Income$67 million

Miscellaneous

Employees78,000
Market Cap$22.10 billion
Next Earnings Date5/8/2019 (Confirmed)
OptionableOptionable

McKesson (NYSE:MCK) Frequently Asked Questions

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, January 31st. Investors of record on Friday, March 1st will be given a dividend of $0.39 per share on Monday, April 1st. This represents a $1.56 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date is Thursday, February 28th. View McKesson's Dividend History.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its quarterly earnings data on Thursday, January, 31st. The company reported $3.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $3.18 by $0.22. The firm had revenue of $56.21 billion for the quarter, compared to analysts' expectations of $55.27 billion. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. During the same period in the previous year, the business posted $3.41 EPS. View McKesson's Earnings History.

When is McKesson's next earnings date?

McKesson is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for McKesson.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY19 earnings guidance on Thursday, January, 31st. The company provided EPS guidance of $13.45-13.65 for the period, compared to the Thomson Reuters consensus estimate of $13.40.

What price target have analysts set for MCK?

13 brokerages have issued 1-year target prices for McKesson's stock. Their predictions range from $2.86 to $175.00. On average, they anticipate McKesson's share price to reach $133.9860 in the next year. This suggests a possible upside of 16.3% from the stock's current price. View Analyst Price Targets for McKesson.

What is the consensus analysts' recommendation for McKesson?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.

Has McKesson been receiving favorable news coverage?

News stories about MCK stock have been trending positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. McKesson earned a news impact score of 2.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.

Are investors shorting McKesson?

McKesson saw a increase in short interest during the month of March. As of March 15th, there was short interest totalling 5,109,995 shares, an increase of 54.5% from the February 28th total of 3,307,858 shares. Based on an average daily volume of 1,746,868 shares, the days-to-cover ratio is currently 2.9 days. Currently, 2.7% of the shares of the stock are sold short. View McKesson's Current Options Chain.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Gilead Sciences (GILD), Allergan (AGN), Walt Disney (DIS), salesforce.com (crm), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Pfizer (PFE), Johnson & Johnson (JNJ) and Chevron (CVX).

Who are McKesson's key executives?

McKesson's management team includes the folowing people:
  • Mr. John H. Hammergren, Chairman & CEO (Age 60)
  • Britt J. Vitalone, CFO & Exec. VP (Age 50)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
  • Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
  • Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

Who are McKesson's major shareholders?

McKesson's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include PGGM Investments (0.16%), Strs Ohio (0.16%), CWM LLC (0.07%), Nisa Investment Advisors LLC (0.05%), Retirement Systems of Alabama (0.05%) and Heritage Investors Management Corp (0.03%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and N Anthony Coles. View Institutional Ownership Trends for McKesson.

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Clarkston Capital Partners LLC, DNB Asset Management AS, Heritage Investors Management Corp, Oakbrook Investments LLC, First Hawaiian Bank, BB&T Corp, Retirement Systems of Alabama and State of Alaska Department of Revenue. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, Lori A Schechter and N Anthony Coles. View Insider Buying and Selling for McKesson.

Which institutional investors are buying McKesson stock?

MCK stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, Gibraltar Capital Management Inc., Pacer Advisors Inc., Legacy Private Trust Co., Mercer Global Advisors Inc. ADV, Mercer Global Advisors Inc. ADV, Exchange Capital Management Inc. and Moon Capital Management LLC. View Insider Buying and Selling for McKesson.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $115.20.

How big of a company is McKesson?

McKesson has a market capitalization of $22.10 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe.

What is McKesson's official website?

The official website for McKesson is http://www.mckesson.com.

How can I contact McKesson?

McKesson's mailing address is ONE POST ST MCKESSON PLAZA, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]


MarketBeat Community Rating for McKesson (NYSE MCK)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  790 (Vote Outperform)
Underperform Votes:  467 (Vote Underperform)
Total Votes:  1,257
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel